8-Quinolinecarboxylic acid, 5-fluoro- – (926252-31-5)

VORTIOXETINE, 508233-74-7, 1-(2-((2, 4-Dimethylphenyl)thio)phenyl)piperazine, Lu AA21004, vortioxetina, 1-{2-[(2, 4-dimethylphenyl)sulfanyl]phenyl}piperazine, Vortioxetine free base, vortioxetinum, UNII-3O2K1S3WQV, 3O2K1S3WQV, LuAA21004, Lu-AA21004, Vortioxetine [USAN], CHEBI:76016, 1-[2-(2, 4-dimethylphenyl)sulfanylphenyl]piperazine, Piperazine, 1-[2-[(2, 4-dimethylphenyl)thio]phenyl]-, HSDB 8250, 508233-74-7 (free base), Piperazine, 1-(2-((2, 4-dimethylphenyl)thio)phenyl)-, Vortioxetine (USAN), Brintellix (TN), 1-(2-(2, 4-dimethylphenylsulfanyl)phenyl)piperazine, 1-[2-(2, 4-dimethyl-phenylsulfanyl)-phenyl]-piperazine, CHEMBL2204360, 1-[2-(2, 4-dimethylphenylsulfanyl)phenyl]piperazine, 1-(2-((2, 4-Dimethylphenyl)sulfanyl)phenyl}piperazine, Vortioxetine [USAN:INN], Piperazine, 1-[2-[(2, 4-dimethylphenyl)thio]phenyl]- 1-[2-(2, 4-Dimethylphenylsulfanyl)phenyl]piperazine Lu AA 21004 Vortioxetine, VTX, PS37 – Vortioxetine, Vortioxetine (Standard), VORTIOXETINE [MI], VORTIOXETINE [INN], VORTIOXETINE [VANDF], Vortioxetine, Lu AA21004, SCHEMBL236115, VORTIOXETINE [WHO-DD], GTPL7351, Vortioxetine (Lu AA21004), CHEMBL2104993, Vortioxetine (Lu AA21004)?, DTXSID80965062, N06AX26, YQNWZWMKLDQSAC-UHFFFAOYSA-N, GLXC-15242, HMS3886M08, BCP05996, QKD31662, BDBM50400902, HY-15414R, s5506, STL483777, AKOS016008748, CCG-229998, CS-1471, DB09068, FD58721, GG-0052, SB16506, compound 5m [PMID: 21486038], NCGC00386237-08, AC-27648, DA-42264, HY-15414, NS00068019, D10184, EN300-746942, AR-270/43507985, Q3563148, 1-[2-(2, 4-Dimethylphenylsulfanyl)-phenyl]piperazine, BRD-K53963539-001-01-8, BRD-K53963539-004-02-0, 1-[2-[(2, 4-Dimethylphenyl)thio]phenyl]-piperazine Vortioxetine 1-(2-((2, 4-Dimethylphenyl)thio)phenyl)piperazine, Lu AA 21004 pound>>LuAA21004 pound>> Lu-AA21004 pound>> Lu AA21004 pound>> AA21004